• Advanced PPM Consulting is a freelance consulting firm focused on implementing innovative project, portfolio and operational excellence best practices for its pharmaceutical and life science partners
• Key offerings include PPM capability building, governance and operating model, R&D roadmap development per Stage Gate, optimized path from strategy to execution, end-to-end program management (Discovery to Ph IV), alliance management, regulatory submissions, "Fit-for-Purpose" PPM systems and tools implementation
• Past engagements (12/2019 – 03/2022) at BMS Oncology/Hematology, Vertex Cell and Genetic Therapies (VCGT) and Gates Medical Research Institute (vaccines and mAbs)
Skills – Matrix Team Leadership, PMO Set-Up & Enhancement, Goal-Setting, Cross-Functional Integration & Alignment, Dashboards/KPIs, Scenario Planning, Timelines/Cost/Resources Optimization, Portfolio Prioritization, Risk & Issue Registers, C-level Presentations and Meeting Management

• Led Program Management Team in supporting Senda's development strategy and execution across 3 Steering Committees and 15 Working Groups. Key focus areas were a) Platform Development (LNP and NNP), b) Research Programs (vaccines and oncology), and c) IND Readiness (e.g., tox study design, clinical, CMC and Regulatory)
• Accountable for 3 joint programs between Senda and external partners; developed "One-Page Strategy" and "Collaborations Dashboard" for strategic alliances and weekly communications with Executive Leadership Team
Skills – Discovery and IND-enabling Program Management, Platform Development, Alliance Management

• Partnered with Executive Leadership Team in establishing the Best-In-Class infrastructure, governance, operating model and PPM systems/tools for R&D Operations (e.g., CMC/IND timelines optimization)
• Led Elevate's most advanced TCR programs from discovery to IND submissions targeting various solid tumors
• Established viral delivery Centre of Excellence in advancing the AAV and Lentivirus technology platforms
Skills – Program Team Building, Discovery and IND-enabling Program Management, CMC

• Responsible for establishing R&D governance/infrastructure and leading company's flagship development programs (against Alzheimer's & Parkinson's Disease) across all UNS' global locations (US, EU and Asia)
• Implemented various PPM best practices including formulation of R&D strategy, Stage-Gate framework (Project Team Guide), 1-yr/3-yr/10-yr development roadmap, portfolio prioritization and mentoring junior members
• Spearheaded key external collaborations and stakeholders/KOLs engagement; hosted quarterly SAB meetings; designed and assembled executive-level presentations for BoD meetings including partnered programs
• Served as Site Head for vaccine product development, platform technology/translational science, CDMO/CMO relationship building, GLP tox and clinical trial supplies
Skills – R&D Governance, Operations, PMO Building and Enhancement, Discovery and Early Phase, CMC

• Established highly-skilled and energized Project Teams with clearly defined vision, growth strategy and operating mechanisms in meeting Ferring's 5-year Business Plan
• Partnered with Clin Ops and Clinical Development Teams to conduct successful clinical trials (Ph II to IV); proactively addressed all key factors that may impact trial enrollment, product safety, efficacy, and reimbursement
• Led cross-functional Due Diligence (DD) and Business Development (BD) Teams to evaluate external opportunities. Enhanced Ferring's DD process to maximize value, speed and Probability of Success (PoS)
• Co-hosted JSC (Joint Steering Committee) meetings for an in-licensed Ph III asset per agreed joint Team Charter
Skills – Late Phase Program Management, Regulatory Strategy, Innovation Lead, BD and Medical Affairs Page 3 of 3

Key member of a global Project Management Office (PMO) with the mission to deliver a large array of complex projects and programs across the $2B pharmaceutical imaging portfolio (oncology, cardiology and neuroscience)
• Provided leadership and in-depth project management expertise to 3 Clinical Program Teams concurrently in conducting Phase II to IV clinical studies as defined by Project Charter, timelines, budgets and ICH/GCP guidelines
• Served as the single point of accountability for all operational aspects of the Project Teams (e.g., from strategy to execution, business case, TPP, timelines, budget & resource optimization, meeting logistics, scope & change management, scenario planning, Risk & Issue Logs, Ad Board, KOL collaborations & Joint Steering Committees)
• As Lead Program Integrator (LPI), spearheaded a company-wide effort in assisting the Executive Team to implement Stage-Gate framework / Phase Review Discipline (PRD) customized for the pharmaceutical imaging business